Access to the most commonly used method of abortion in the United States plunged into uncertainty on Friday following conflicting court rulings over the legality of the abortion medication mifepristone that has been widely available for more than 20 years.
For now, the drug that the Food and Drug Administration (FDA) approved in 2000 remains at least immediately available in the wake of the separate rulings that were issued just minutes apart by federal judges in Texas and Washington state.
U.S. District Judge Matthew Kacsmaryk, a Trump appointee, ordered a hold on federal approval of mifepristone in a decision that overruled decades
